These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21803635)

  • 1. Biotherapy and rheumatoid arthritis: a medico-economic evaluation from 2008 French Hospital Database.
    Maravic M; Baudens G; Sanchez JP; Flipo RM; Toubiana L; Landais P
    Joint Bone Spine; 2012 Jan; 79(1):96-7. PubMed ID: 21803635
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale of using different biological therapies in rheumatoid arthritis.
    Geyer M; Müller-Ladner U
    Arthritis Res Ther; 2010; 12(4):214. PubMed ID: 20735862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proposal for biologic drugs therapy in rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S; Kaliterna DM; Hanih M; Novak S
    Reumatizam; 2010; 57(1):29-35. PubMed ID: 20941938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A change in treatment from etanercept to infliximab was effective to control scleritis in a patient with rheumatoid arthritis.
    Sassa Y; Kawano Y; Yamana T; Mashima T; Ishibashi T
    Acta Ophthalmol; 2012 Mar; 90(2):e161-2. PubMed ID: 21470384
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic impact of rheumatoid arthritis (RA) biotherapies in France.
    Maravic M
    Joint Bone Spine; 2010 Jul; 77(4):319-24. PubMed ID: 20493751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
    Favalli EG; Biggioggero M; Marchesoni A; Meroni PL
    Rheumatology (Oxford); 2014 Sep; 53(9):1664-8. PubMed ID: 24729445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission in early rheumatoid arthritis.
    Ma MH; Scott IC; Kingsley GH; Scott DL
    J Rheumatol; 2010 Jul; 37(7):1444-53. PubMed ID: 20516031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated medication costs of primary TNFα antagonist failure in patients with rheumatoid arthritis.
    Rose E; Lequerré T; Pouplin S; Daragon A; Le Loët X; Vittecoq O
    Joint Bone Spine; 2012 Jul; 79(4):421-2. PubMed ID: 22512937
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis.
    Zhou ZY; Griffith J; Du EX; Chin D; Betts KA; Ganguli A
    Adv Ther; 2016 May; 33(5):807-23. PubMed ID: 27084724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis.
    Braun J; Kalden JR
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S164-7. PubMed ID: 19822066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy for rheumatoid arthritis in developing countries--a place for non-TNF inhibitors as first-line treatment?
    Tikly M; Hodkinson B; Dheda K
    Rheumatology (Oxford); 2015 Feb; 54(2):208-9. PubMed ID: 24692577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adalimumab in advanced and early rheumatoid arthritis].
    Szekanecz Z
    Orv Hetil; 2009 Jul; 150(28):1333-4. PubMed ID: 19581162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of biological treatments based on ACR70 response in rheumatoid arthritis: indirect comparison and meta-regression using Bayes-model].
    Brodszky V
    Orv Hetil; 2011 Jun; 152(23):919-28. PubMed ID: 21592952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

  • 17. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
    van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
    Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
    [No Abstract]   [Full Text] [Related]  

  • 18. When is it not ethical to withhold treatment for rheumatoid arthritis?
    Yazici Y
    Ann Rheum Dis; 2014 May; 73(5):e25. PubMed ID: 24368513
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
    Dahlin J; Sørensen SF
    Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
    [No Abstract]   [Full Text] [Related]  

  • 20. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
    Pixley J; Wolf B; O'Neill W
    Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.